 |
Feb 09,
2010 |
Tuesday's biggest gaining and declining stocks, MarketWatch.com |
|
Stocks seeing big moves in trading include AMR, Cerus and Electronic Arts. |
|
Feb 09,
2010 |
Treasurys down after auction, news of Greece plan, MarketWatch.com |
|
Treasury prices decline and yields rise for a second straight session, as investors cheer reports of a European rescue of Greece and the government's auction draws lackluster demand. |
|
Feb 09,
2010 |
Financials join party as bank gains lift sector, MarketWatch.com |
|
Shares of financial stocks add to earlier gains as banks large and small take a leadership role, with fears of a European debt crisis ebbing and investor sentiment rising in the broader market. |
|
Feb 09,
2010 |
U.S. stocks pick up steam; Dow rises triple-digits, MarketWatch.com |
|
U.S. stocks rally sharply Tuesday, with the Dow industrials average adding more than 230 points at one point, after a report suggesting a German government bailout of Greece clipped fears of another global financial crisis, and battered the U.S. dollar. |
|
Feb 09,
2010 |
Dollar drops against euro on news of Greek rescue, MarketWatch.com |
|
The dollar extends losses versus the euro, briefly pushing the shared currency up 1.3%, as speculation mounts over a possible rescue of Greece and other heavily-indebted southern European countries. |
|
Feb 09,
2010 |
Gold rallies on report of Greek bailout, MarketWatch.com |
|
Gold and metals futures rally, as a report that Germany may rescue Greece from its debts boosts the euro, pressuring the dollar and lifting the price of commodities. |
|
Feb 09,
2010 |
Updates, advisories and surprises, MarketWatch.com |
|
A roundup of the latest corporate earnings reports and what companies are saying about future quarters. |
|
Feb 09,
2010 |
Cell Therapeutics, AstraZeneca lead drug stocks, MarketWatch.com |
|
Drug stocks gain while shares of Cell Therapeutics bounce back after diving almost 25% over concerns about its new non-Hodgkin's lymphoma treatment pixantrone. |
|
Feb 09,
2010 |
Biogen reports higher profit, raises forecast, MarketWatch.com |
|
An almost 40% jump in sales of its new multiple sclerosis drug Tysabri helps Biogen to higher profit. |
|
Feb 09,
2010 |
Pulte sees smaller loss after charges, tax gains, MarketWatch.com |
|
The home-building giant that acquired Centex last year narrows its fourth-quarter loss as its bottom line is hit by charges of more than $900 million. |
 more... |
| |